Ahead of its second anniversary, Tata Neu, the multi-purpose super app of the Tata group is refreshing its design, and may also venture into the online food delivery space by leveraging the Open Network for Digital Commerce (ONDC), sources said. The salt-to-steel conglomerate’s ambitious e-commerce project has embarked on a sleek, immersive design,… Continue reading Tata Neu changes its look with a new UI, eyes online food delivery foray | Company News
Tag: eyes
Metropolis Healthcare eyes 60% revenue from B2C business in next 2-3 years
Mumbai-headquartered diagnostic services provider Metropolis Healthcare is eyeing 60 per cent of its revenues from the business-to-consumer (B2C) segment in the next two-three years. The company’s current share in the segment is 52 per cent. As Metropolis focuses on aggressive network expansion, it has been growing its B2C segment. This includes both the prescription-led… Continue reading Metropolis Healthcare eyes 60% revenue from B2C business in next 2-3 years
Macrotech eyes Rs 12k-cr sales revenue from land parcels in MMR, Bengaluru
Realty firm Macrotech Developers Ltd has acquired five land parcels in Mumbai region and Bengaluru during April-June quarter to develop housing projects with a revenue potential of Rs 12,000 crore. Macrotech Developers MD and CEO Abhishek Lodha said the company has added new projects worth Rs 12,000 crore in the first quarter of… Continue reading Macrotech eyes Rs 12k-cr sales revenue from land parcels in MMR, Bengaluru
All eyes on India’s young guns in Trinidad
After leading India to a 2-1 ODI series win, Hardik Pandya will lead the Men In Blue in the first of the five-match series against West Indies at Brian Lara Stadium, Tarouba, Trinidad today. India will be without their senior players, and it will be a good opportunity for the youngsters to express themselves… Continue reading All eyes on India’s young guns in Trinidad
Sanghi Ind freezes at 5% upper circuit as Ambuja eyes buying majority stake
Shares of Sanghi Industries were locked in the 5 per cent upper circuit at Rs 100.73 on the BSE on Wednesday after a Reuters report said that Ambuja Cements has reached a deal to acquire a majority stake in the company. The deal valuation is expected to be pegged at Rs 6,000 crore. A combined… Continue reading Sanghi Ind freezes at 5% upper circuit as Ambuja eyes buying majority stake
Roastea eyes Rs 100 cr in topline; to install 5,000 vending machines
Beverage startup, Roastea is eying Rs 100 crore turnover and 5,000 vending machines network by 2024-25. “The company’s tea and coffee vending machine business will be one of the key drivers of growth, and it aims to roll out over 1,500 such machines this year, aggregating to 2,500 machines,” a company statement said Roastea… Continue reading Roastea eyes Rs 100 cr in topline; to install 5,000 vending machines
Nifty Financial Services may see correction; PSB index eyes profit booking
The Nifty Financial Services index (current market price: 20342.05) has recently shown signs of near-term range-bound movement on charts. Investors are closely monitoring the index’s behavior within the range of 20415 to 20180, as a trade above or below this range could trigger significant directional movements. The primary support levels to watch are set at… Continue reading Nifty Financial Services may see correction; PSB index eyes profit booking
Petronet eyes lower prices under renewed long-term deal with Qatar
By Nidhi Verma NEW DELHI (Reuters) – India’s Petronet LNG hopes to extend its long-term gas import deal with Qatar at lower prices than those offered by the world’s top liquefied natural gas (LNG) exporter in recent deals with China and Bangladesh. Indications are that the deals have been done at a… Continue reading Petronet eyes lower prices under renewed long-term deal with Qatar
Jhunjhunwala-backed Concord Biotech eyes to raise Rs 1,550 cr through IPO
Ahmedabad-based Concord Biotech, makers of fermentation-based bulk drugs, is aiming to raise between Rs 1,475.26 crore and Rs 1,550.59 crore from an initial public offering (IPO) set to open on Friday. Rakesh Jhunjhunwala-backed Concord Biotech Ltd has fixed a price band between Rs 705 and Rs 741 a share. The public issue of… Continue reading Jhunjhunwala-backed Concord Biotech eyes to raise Rs 1,550 cr through IPO
Tredence eyes acquisitions in BFS, healthcare vertical by year end
Premium Shub Bhowmick, Co-founder & CEO, Tredence Advent-backed data science and analytics firm Tredence is eying for acquisitions in the Banking & Financial Services (BFS) or healthcare domain by the end of this year or the first quarter of the next calendar year. “We have set up the corporate M&A office, and we… Continue reading Tredence eyes acquisitions in BFS, healthcare vertical by year end